HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Tatsumi Selected Research

Subcutaneous Injections

1/2010Mutant mouse p53 transgene elevates the chemical induction of tumors that respond to gene silencing with siRNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Tatsumi Research Topics

Disease

8Neoplasms (Cancer)
10/2015 - 11/2001
3Pulmonary Hypertension
01/2005 - 02/2000
3Chronic Obstructive Pulmonary Disease (COPD)
08/2002 - 01/2000
2Lung Diseases (Lung Disease)
06/2018 - 03/2001
2Hemorrhage
01/2016 - 11/2013
2Infections
01/2016 - 01/2015
2Peritonitis
01/2015 - 03/2011
2Mesothelioma
11/2014 - 03/2012
2Allergic Rhinitis
02/2014 - 01/2007
2Carcinoma (Carcinomatosis)
01/2014 - 11/2004
2Hemophilia A (Haemophilia)
11/2013 - 08/2008
2Hypoxia (Hypoxemia)
08/2002 - 11/2000
1Pancreatic Neoplasms (Pancreatic Cancer)
09/2015
1Anastomotic Leak
01/2015
1Melanoma (Melanoma, Malignant)
01/2014
1Hemophilia B (Haemophilia B)
11/2013
1Malignant Mesothelioma
03/2012
1Inflammation (Inflammations)
11/2011
1Pre-Eclampsia (Preeclampsia)
10/2011
1Choriocarcinoma
10/2011
1Hypertension (High Blood Pressure)
06/2011
1Endometriosis
04/2011
1Fibrosarcoma
01/2010
1Neuroblastoma
08/2005
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2005
1Neoplasm Metastasis (Metastasis)
11/2004
1Rheumatoid Arthritis
02/2003
1Renal Insufficiency (Renal Failure)
01/2003
1Lung Neoplasms (Lung Cancer)
01/2003
1Body Weight (Weight, Body)
08/2002
1Ataxia Telangiectasia (Louis Bar Syndrome)
11/2001
1Carcinogenesis
11/2001
1Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
10/2001
1Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi)
05/2001
1Peroxisome biogenesis disorders
03/2001

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
11/2014 - 12/2000
2AntigensIBA
10/2015 - 01/2001
2InterleukinsIBA
10/2015 - 01/2014
2DNA (Deoxyribonucleic Acid)IBA
10/2015 - 09/2000
2NitrogenIBA
11/2014 - 08/2002
2Cisplatin (Platino)FDA LinkGeneric
03/2012 - 01/2003
2Small Interfering RNA (siRNA)IBA
01/2010 - 08/2005
1MacrolidesIBA
06/2018
1Thromboplastin (Tissue Factor)IBA
01/2016
1Hemostatics (Antihemorrhagics)IBA
01/2016
1SurvivinIBA
09/2015
1CaspasesIBA
09/2015
1MidkineIBA
09/2015
1Type II DNA Topoisomerases (Topoisomerase II)IBA
11/2014
1Monomeric GTP-Binding ProteinsIBA
11/2014
1Diphosphonates (Bisphosphonates)IBA
11/2014
1Zoledronic Acid (Zometa)FDA Link
11/2014
1Immunoglobulin E (IgE)IBA
02/2014
1OvalbuminIBA
02/2014
1interleukin-22 receptor (IL-22R)IBA
01/2014
1Cyclin-Dependent Kinase Inhibitor p16IBA
03/2012
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
03/2012
1Pemetrexed (MTA)FDA Link
03/2012
1ChemokinesIBA
11/2011
1Nerve Growth Factors (Neurotrophins)IBA
10/2011
1Messenger RNA (mRNA)IBA
10/2011
1Branched-Chain Amino AcidsIBA
06/2011
1ProgesteroneFDA LinkGeneric
04/2011
1Estradiol (Delestrogen)FDA LinkGeneric
04/2011
1urinastatin (MR 20)IBA
03/2011
1MethylcholanthreneIBA
01/2010
1atelocollagenIBA
01/2010
1Complementary DNA (cDNA)IBA
01/2010
1Actins (F Actin)IBA
01/2010
1Factor VIII (Coagulation Factor VIII)IBA
08/2008
1Fas Ligand Protein (Fas Ligand)IBA
03/2007
1Interleukin-4 (Interleukin 4)IBA
01/2007
1Immunoglobulin G (IgG)IBA
01/2007
1HLA-B Antigens (HLA-B)IBA
01/2005
1HLA-B*52:01 antigenIBA
01/2005
1Interleukin-22 (IL-22)IBA
11/2004
1AutoantibodiesIBA
02/2003
1Etoposide (VP 16)FDA LinkGeneric
01/2003
1PlatinumIBA
01/2003
1Insulin-Like Growth Factor I (IGF-1)IBA
08/2002
1Anabolic AgentsIBA
08/2002
1AntibodiesIBA
11/2001
1Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA
11/2001
1Monoclonal AntibodiesIBA
11/2001
1SteroidsIBA
10/2001
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
05/2001
1GangliosidesIBA
03/2001
1beraprostIBA
03/2001
1Epoprostenol (Prostacyclin)FDA LinkGeneric
03/2001

Therapy/Procedure

1Immunotherapy
10/2015
1Conservative Treatment
01/2015
1Catheters
01/2015
1Total Parenteral Nutrition
01/2015
1Operative Surgical Procedures
11/2013
1Laparotomy
11/2013
1Immunomodulation
10/2011
1High-Protein Diet
06/2011
1Subcutaneous Injections
01/2010
1Drug Therapy (Chemotherapy)
01/2003
1Combination Drug Therapy (Combination Chemotherapy)
01/2003